Mefar Ilac Sanayii AS
Mefar Ilac Sanayii AS, a prominent player in the pharmaceutical industry, is headquartered in Turkey (TR) and operates extensively across various regions. Founded in 1984, the company has established itself as a leader in the production of high-quality pharmaceutical products, including injectables, oral solids, and sterile solutions. Mefar's commitment to innovation and quality has led to significant milestones, such as the expansion of its manufacturing facilities and the introduction of advanced technologies in drug production. Renowned for its rigorous quality control processes, Mefar Ilac stands out in the market with its unique formulations and a diverse product portfolio that caters to both domestic and international markets. With a strong market position, Mefar Ilac Sanayii AS continues to achieve notable recognition for its contributions to healthcare, ensuring the delivery of safe and effective medications to patients worldwide.
DitchCarbon Score
How does Mefar Ilac Sanayii AS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mefar Ilac Sanayii AS's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mefar Ilac Sanayii AS's reported carbon emissions
Mefar Ilac Sanayii AS, headquartered in Turkey (TR), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, Mefar Ilac Sanayii AS may inherit climate-related data and commitments from its parent organisation; however, no specific details or figures have been provided regarding such cascaded information. The company appears to be in the early stages of establishing its climate commitments and emissions reporting framework. In the context of the pharmaceutical industry, it is increasingly important for companies to set measurable climate targets and engage in sustainability initiatives to mitigate their environmental impact. Mefar Ilac Sanayii AS will need to develop and communicate its strategies to align with industry standards and expectations for carbon emissions reduction.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mefar Ilac Sanayii AS is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
